Study With a Topical Gel to Treat Common Warts in Adults

Graceway Pharmaceuticals, LLC48 enrolled

Overview

The primary purpose of this study is to evaluate the effectiveness in adults of 2 different strengths of resiquimod gel applied to common wart(s) five times a week for up to 12 weeks. A second purpose is to evaluate the safety of the drug.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Warts

Interventions

ResiquimodDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosis of common warts * Two forms of birth control Exclusion Criteria: * Pregnant or breast feeding * Other types of warts, ie. plantar * Currently participating in another clinical study * Chronic viral hepatitis B or C

Locations (1)

Minnesota Clinical Study Center

Fridley, Minnesota, United States

Outcomes

Primary Outcomes

Clearance of treated wart(s)

Secondary Outcomes

Partial clearance of treated wart(s)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.